ATE362107T1 - Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker - Google Patents

Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker

Info

Publication number
ATE362107T1
ATE362107T1 AT01989101T AT01989101T ATE362107T1 AT E362107 T1 ATE362107 T1 AT E362107T1 AT 01989101 T AT01989101 T AT 01989101T AT 01989101 T AT01989101 T AT 01989101T AT E362107 T1 ATE362107 T1 AT E362107T1
Authority
AT
Austria
Prior art keywords
prostate
markers
detection
quantitative detection
specific membrane
Prior art date
Application number
AT01989101T
Other languages
English (en)
Inventor
George Wright
Original Assignee
Eastern Virginia Med School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastern Virginia Med School filed Critical Eastern Virginia Med School
Application granted granted Critical
Publication of ATE362107T1 publication Critical patent/ATE362107T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Optics & Photonics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Peptides Or Proteins (AREA)
AT01989101T 2000-11-20 2001-11-16 Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker ATE362107T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25245200P 2000-11-20 2000-11-20

Publications (1)

Publication Number Publication Date
ATE362107T1 true ATE362107T1 (de) 2007-06-15

Family

ID=22956064

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01989101T ATE362107T1 (de) 2000-11-20 2001-11-16 Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker

Country Status (9)

Country Link
EP (1) EP1390523B1 (de)
JP (1) JP2004536278A (de)
KR (1) KR20030066672A (de)
CN (1) CN1537170A (de)
AT (1) ATE362107T1 (de)
AU (2) AU4322102A (de)
CA (1) CA2428011A1 (de)
DE (1) DE60128404D1 (de)
WO (1) WO2002046448A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050215472A1 (en) 2001-10-23 2005-09-29 Psma Development Company, Llc PSMA formulations and uses thereof
JP5355839B2 (ja) 2001-10-23 2013-11-27 ピーエスエムエー デベロプメント カンパニー， エル．エル．シー． Ｐｓｍａ抗体およびタンパク質マルチマー
GB0305656D0 (en) * 2003-03-12 2003-04-16 Bioinvent Int Ab Screening assay
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
CA2645809C (en) * 2006-03-14 2015-05-26 Cancer Targeted Technology Llc Peptidomimetic inhibitors of psma, compounds comprising them, and methods of use
JP4995194B2 (ja) * 2006-05-10 2012-08-08 あすか製薬株式会社 前立腺癌と良性前立腺過形成の鑑別法
AU2007284651B2 (en) * 2006-08-09 2014-03-20 Institute For Systems Biology Organ-specific proteins and methods of their use
CN101158666B (zh) * 2006-10-08 2012-06-27 许洋 一种用含有抗体组的基质去捕获生物样品中生物标志的分析方法
EP2136843A1 (de) 2007-03-12 2009-12-30 Miraculins Inc. Biomarker für prostatakrebs und ihre verwendungen
WO2008136912A1 (en) 2007-05-07 2008-11-13 Massachusetts Institute Of Technology Polymer sheets and other bodies having oriented chains and method and apparatus for producing same
EP2315858A2 (de) * 2008-07-08 2011-05-04 Source Precision Medicine, Inc. Erstellung von genexpressionsprofilen zur vorhersage der überlebenschancen von patienten mit prostatakrebs
ES2712732T3 (es) * 2009-02-17 2019-05-14 Cornell Res Foundation Inc Métodos y kits para el diagnóstico de cáncer y la predicción de valor terapéutico
JP5222906B2 (ja) * 2010-07-20 2013-06-26 株式会社日立ハイテクノロジーズ 生体試料の分析方法
CN102998448A (zh) * 2011-09-09 2013-03-27 上海市计划生育科学研究所 来源于前列腺分泌液中的前列腺癌标记物
CN102409091A (zh) * 2011-10-17 2012-04-11 刘颜 前列腺分泌蛋白94/57作为卵巢癌、乳腺癌早期临床诊断生物标记物的方法
MY193914A (en) 2012-03-05 2022-11-01 Oy Arctic Partners Ab Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume
JP5429725B1 (ja) * 2013-03-22 2014-02-26 独立行政法人理化学研究所 前立腺癌の進行度の評価方法、前立腺癌の検出方法、および検査キット
ES2545873T3 (es) * 2013-05-23 2015-09-16 Bruker Daltonik Gmbh Determinación de resistencia con espectrometría de masas mediante la medición de la proliferación microbiana
DK3123381T3 (da) 2014-03-28 2023-11-27 Opko Diagnostics Llc Sammensætninger og fremgangsmåder relateret til diagnose af prostatacancer
US12326453B2 (en) 2014-03-28 2025-06-10 Opko Diagnostics, Llc Compositions and methods for active surveillance of prostate cancer
GB2535835B (en) * 2014-12-17 2019-09-04 Micromass Ltd A two-dimensional separation and imaging technique for the rapid analysis of biological samples
WO2016160545A1 (en) 2015-03-27 2016-10-06 Opko Diagnostics, Llc Prostate antigen standards and uses thereof
CN117169534A (zh) 2019-08-05 2023-12-05 禧尔公司 用于样品制备、数据生成和蛋白质冠分析的系统和方法
GB202111635D0 (en) * 2021-08-13 2021-09-29 Randox Laboratories Risk prediction model for prostate cancer
CN114292918A (zh) * 2021-12-31 2022-04-08 刘飞 一种基于LncRNA546标志物的前列腺癌早期诊断方法
CN115711933A (zh) * 2022-11-10 2023-02-24 广东省人民医院 检测试剂、检测试剂盒及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69334071T2 (de) * 1992-11-05 2007-10-25 Sloan-Kettering Institute For Cancer Research Prostata-spezifisches membranantigen
AU6551398A (en) * 1997-03-11 1998-09-29 Anna C. Ferrari Method of detecting prostate cancer metastasis
WO2000050457A1 (en) * 1999-02-22 2000-08-31 Beckman Coulter, Inc. Prostate-specific membrane antigens and methods of making and using
CN1426536A (zh) * 2000-03-20 2003-06-25 东弗吉尼亚医学院 前列腺癌标记
US6379550B1 (en) * 2000-07-24 2002-04-30 Health Research, Inc. Method for detecting PSA and its molecular forms using thiophilic gel

Also Published As

Publication number Publication date
EP1390523B1 (de) 2007-05-09
CN1537170A (zh) 2004-10-13
CA2428011A1 (en) 2002-06-13
AU4322102A (en) 2002-06-18
EP1390523A2 (de) 2004-02-25
JP2004536278A (ja) 2004-12-02
AU2002243221B2 (en) 2006-11-09
WO2002046448A3 (en) 2003-12-11
DE60128404D1 (de) 2007-06-21
KR20030066672A (ko) 2003-08-09
EP1390523A4 (de) 2004-03-31
WO2002046448A2 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
ATE362107T1 (de) Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker
DE60029369D1 (de) Verfahren und Sondenset zur Erkennung von Krebs
WO2005019477A3 (en) Methods and compositions for differentiating tissues or cell types using epigenetic markers
ATE469219T1 (de) Zusammensetzungen, methoden und reagentien zur nukleinsäureisolierung mittels oberflächenaktiven substanzen und proteasen
ATE212674T1 (de) Verfahren und analytisches system zur genauen schnellen und einfachen ausführung von fibrinogen-assays
ATE350488T1 (de) Verfahren und testsysteme zur identifizierung von elite event gat-zm1 in biologischen proben
ATE385259T1 (de) Verfahren zum nachweis von influenza a/b-viren in speichel
ATE462492T1 (de) Vorrichtung zur detektion von targetmolekülen
DE59609347D1 (de) Verfahren zur quantifizierung von tumorzellen in einer körperflüssigkeit und dazu geeignete testkits
EP1362124A4 (de) Verfahren und sonden für den nachweis von krebs
WO2002022879A3 (en) Detection of microsatellite instability and its use in diagnosis of tumors
DK0975800T3 (da) Analyse af nukleotider i opløsning under anvendelse af PNA-prober
WO2002048674A3 (en) Methods, devices, arrays and kits for detecting and analyzing biomolecules
BR0206145A (pt) Sistema de teste indicador com tira reagente para uso em lìquidos para a detecção e/ou determinação de sequências especìficas de ácido nucléico
IL157917A0 (en) Method for sample identification in a mammal as well as a kit for performing this method
AU2003260457A1 (en) A method and kit for the quantitative and/or qualitative detection of components in a sample
DE60031204D1 (de) VERFAHREN und KIT ZUM NACHWEIS UND ZUR IDENTIFIZIERUNG VON KRISTALLEN IN BIOLOGISCHEN FLÜSSIGKEITEN
BRPI0414283A (pt) métodos, composições e kits para a concentração e detecção de microorganismos
EP1392362A4 (de) Nachweis von legionella mit echtzeit-pcr und fluoreszenz-resonanz-energie-transfer
ATE541945T1 (de) Nachweis und quantifizierung fäkaler verunreinigungen in umweltproben
SE0002287D0 (sv) Biotinderivat
ATE272718T1 (de) Verfahren zur bestimmung von disaccharidasen
DE50110172D1 (de) Verfahren zur altersbestimmung von individuen
DK1337849T3 (da) Fremgangsmåder og sammensætninger til at sortere og/eller bestemme mikroorganismer
DE60109733D1 (de) Verfahren zur immobilisierung von affinen reagentien an hydrophoben festphasen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties